kabutan

Techno Medica, Jul-Sep (2Q) Ordinary Profit Increases by 6.3 times

Fri Nov 7, 2025 3:30 pm JST Earnings

6678 Techno Medica Co., Ltd. 【J-GAAP】

Earnings Report

Techno Medica Co., Ltd. <6678> [TSE Std] announced its financial results after the market closed on November 7th (15:30). The ordinary profit (non-consolidated) for the cumulative second quarter of the fiscal year ending March 2026 (April to September) was 0.29 billion yen, a 1.3% decrease compared to the same period last year. Progress toward the full-year plan of 1.48 billion yen was 19.9%, also falling below the five-year average of 28.1%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary profit for the October to March period (second half) is expected to grow 18.0% from the same period last year, reaching 1.18 billion yen.

In the most recent three-month period, from July to September (2Q), the ordinary profit surged 6.3 times that of the same period last year, reaching 0.27 billion yen. The operating profit margin drastically improved from 2.6% in the same period last year to 11.4%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2023 4,056 523 533 376 46.2 28.5 Nov 7, 2023 J-GAAP
Apr - Sep, 2024 4,116 304 298 221 32.1 22.9 Nov 7, 2024 J-GAAP
Apr - Sep, 2025 4,104 266 294 203 29.3 19.9 Nov 7, 2025 J-GAAP
YoY -0.3% -12.5% -1.3% -8.1% -8.6%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 Guidance 4,000 150 150 110 15.8 0 May 9, 2025 J-GAAP
Apr - Sep, 2025 Results 4,104 266 294 203 29.3 0 Nov 7, 2025 J-GAAP
Revision Rate +2.6% +77.3% +96.0% +84.5% +85.0%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 5,789 996 1,005 783 113.2 68 May 9, 2025 J-GAAP
Oct - Mar, 2025 Guidance 6,496 1,214 1,186 897 128.7 68 Nov 7, 2025 J-GAAP
YoY +12.2% +21.9% +18.0% +14.6% +13.7%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 10,283 1,840 1,870 1,348 173.0 68 May 9, 2024 J-GAAP
Mar, 2025 9,905 1,300 1,303 1,004 145.1 68 May 9, 2025 J-GAAP
Mar, 2026 Guidance 10,600 1,480 1,480 1,100 157.8 68 May 9, 2025 J-GAAP
YoY +7.0% +13.8% +13.6% +9.6% +8.8%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 2,117 54 43 48 7.0 2.6 Nov 7, 2024 J-GAAP
Oct - Dec, 2024 2,331 280 291 205 29.7 12.0 Feb 5, 2025 J-GAAP
Jan - Mar, 2025 3,458 716 714 578 83.5 20.7 May 9, 2025 J-GAAP
Apr - Jun, 2025 1,757 -2 23 16 2.4 -0.1 Aug 6, 2025 J-GAAP
Jul - Sep, 2025 2,347 268 271 187 27.0 11.4 Nov 7, 2025 J-GAAP
YoY +10.9% +396.3% +530.2% +289.6% +287.9%

Related Articles